Timothy Shaw - 29 Nov 2025 Form 4 Insider Report for MARIMED INC. (MRMD)

Role
Chief Operating Officer
Signature
/s/ Timothy Shaw
Issuer symbol
MRMD
Transactions as of
29 Nov 2025
Transactions value $
-$2,137
Form type
4
Filing time
02 Dec 2025, 16:06:03 UTC
Previous filing
28 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shaw Timothy Chief Operating Officer C/O MARIMED INC., 10 OCEANA WAY, NORWOOD, /s/ Timothy Shaw 01 Dec 2025 0001866577

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRMD Common stock Options Exercise $0 +81,250 +0.89% $0 9,215,162 29 Nov 2025 Direct F1
transaction MRMD Common stock Tax liability -$2,136 -23,847 -0.26% $0.0896 9,191,315 29 Nov 2025 Direct F2
holding MRMD Common stock 2,000,000 29 Nov 2025 By the Shaw Family Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRMD Restricted Stock Units (RSU) Options Exercise $0 -81,250 -33.33% $0 162,500 29 Nov 2025 Common Stock, par value $.001 per share 81,250 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RSUs convert to shares of common stock on a one-for-one basis.
F2 Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
F3 The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4 These RSUs were granted on November 29, 2024; the remaining RSUs under this grant will vest in four equal installments, on each of May 29, 2026, November 29, 2026, May 29, 2027 and November 29, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.